Amneal ‘Very Excited’ About Biosimilars Future, Looks To Expand Portfolio In 2024
Complex Generics Also Remain Key R&D Focus Area, Particularly Inhalators And Injectables
Amneal said the “next wave of affordable medicines is biosimilars” • Source: Shutterstock 
